Barinthus Biotherapeutics plc - American Depositary Shares — Quarterly Financial Statistics (NASDAQ:BRNS)

Financials

Overview Relatórios Statistics Dividends

Cash from operating activities 18.2 M-13.09 M14.9 M18.11 M10.73 M 30.65 M Cash from investing activities 114 K278 K5 00032 K377 K 692 K Cash from financing activities 465 K837 K2 00000 839 K Free cash flow 18.08 M-13.36 M14.9 M18.08 M10.73 M 30.34 M

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

BRNS

Financials

Barinthus Biotherapeutics plc - American Depositary Shares

Notícias

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

Barinthus Bio divulga dados iniciais positivos de ensaio com terapia para doença celíaca

Barinthus Bio reports positive initial data from celiac therapy trial

H.C. Wainwright reitera classificação de Compra para ações da Barinthus Biotherapeutics

Barinthus Biotherapeutics stock rating reiterated at Buy by H.C. Wainwright

Barinthus Bio and Clywedog to merge in all-stock deal

Barinthus Biotherapeutics’ CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025